NaV1.2 and 1.3 are primarily expressed in the central nervous system and involved in the pathomechanisms of epilepsy, while NaV1.7 is in the peripheral nervous system and plays a role in neuropathic pain [36,37,38]. Here, SCN9A is linked to epilepsy.